| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |